Dashboard
Boehringer Ingelheim leads the named-sponsor description-black-box stock, Pfizer and Roche follow, and industry dominates the sponsor-class rate table.
Boehringer Ingelheim leads the named-sponsor description-black-box table, Pfizer and Roche follow, Mylan is the sharpest large-sponsor rate outlier, and industry dominates the sponsor-class rate comparison.
Boehringer Ingelheim leads the named-sponsor description-black-box stock, Pfizer and Roche follow, and industry dominates the sponsor-class rate table.
Each project isolates a different dimension of registry opacity, but the point is the contrast between them, not a single leaderboard.
Industry project from the CT.gov hiddenness series.
Sponsor-class project from the CT.gov hiddenness series.
Phase project from the CT.gov hiddenness series.
Structural missingness project from the CT.gov hiddenness series.
Evidence visibility project from the CT.gov hiddenness series.
Completion cohort project from the CT.gov hiddenness series.
Condition hiddenness project from the CT.gov hiddenness series.
Sponsor concentration project from the CT.gov hiddenness series.
Rule-era reporting project from the CT.gov hiddenness series.
Publication undercount audit from the CT.gov hiddenness series.
Oncology hiddenness project from the CT.gov hiddenness series.
Cardiovascular hiddenness project from the CT.gov hiddenness series.
Metabolic hiddenness project from the CT.gov hiddenness series.
Enrollment-size project from the CT.gov hiddenness series.
Geography-scale project from the CT.gov hiddenness series.
Design-purpose project from the CT.gov hiddenness series.
Completion-delay project from the CT.gov hiddenness series.
Trial-architecture project from the CT.gov hiddenness series.
Intervention-type project from the CT.gov hiddenness series.
Country reporting project from the CT.gov hiddenness series.
Stopped-trial project from the CT.gov hiddenness series.
Outcome-density project from the CT.gov hiddenness series.
Actual-field project from the CT.gov hiddenness series.
US-versus-global project from the CT.gov hiddenness series.
Modality-sponsor project from the CT.gov hiddenness series.
Country-condition project from the CT.gov hiddenness series.
Disease-geography project from the CT.gov hiddenness series.
Condition-sponsor project from the CT.gov hiddenness series.
Country-sponsor project from the CT.gov hiddenness series.
US-versus-ex-US project from the CT.gov hiddenness series.
Industry-family project from the CT.gov hiddenness series.
Risk-adjusted hiddenness from the CT.gov hiddenness series.
Overdue results clock from the CT.gov hiddenness series.
Publication index gap from the CT.gov hiddenness series.
Probable ACT/FDAAA debt from the CT.gov hiddenness series.
Sponsor excess watchlist from the CT.gov hiddenness series.
Country excess watchlist from the CT.gov hiddenness series.
Condition excess watchlist from the CT.gov hiddenness series.
Black-box trials from the CT.gov hiddenness series.
Strict-proxy repeaters from the CT.gov hiddenness series.
Sponsor ghost repeaters from the CT.gov hiddenness series.
Country ghost watchlist from the CT.gov hiddenness series.
Condition ghost watchlist from the CT.gov hiddenness series.
Black-box sponsor repeaters from the CT.gov hiddenness series.
Strict-core black-box from the CT.gov hiddenness series.
Sponsor overdue debt from the CT.gov hiddenness series.
Country overdue debt from the CT.gov hiddenness series.
Condition overdue debt from the CT.gov hiddenness series.
Narrative-gap repeaters from the CT.gov hiddenness series.
Actual-discipline repeaters from the CT.gov hiddenness series.
Sponsor ancient backlog from the CT.gov hiddenness series.
Country ancient backlog from the CT.gov hiddenness series.
Condition ancient backlog from the CT.gov hiddenness series.
Completion-timing repeaters from the CT.gov hiddenness series.
Named-sponsor tables showing which portfolios still hold the oldest unresolved CT.gov studies more than a decade past deadline.
Country-linked tables showing where the oldest unresolved CT.gov stock still accumulates after the reporting window closed long ago.
Condition-family tables showing which therapeutic portfolios still carry the oldest unresolved CT.gov studies.
Named-sponsor tables for older CT.gov studies missing actual primary completion or actual completion timing fields.